Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04205708 · ClinicalTrials.gov registry record
Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma
A clinical trial of Silicosis and Pneumoconiosis; Silica, sponsored by University of Oklahoma.
- Completed
- Registry status
- 183
- Enrollment target
- 1
- Study location
NCT04205708: Completed study of Silicosis and Pneumoconiosis; Silica, sponsored by University of Oklahoma.
NCT04205708 is a study of Silicosis and Pneumoconiosis; Silica that has completed, run by University of Oklahoma. The registered enrollment target is 183 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04205708, a study of Silicosis and Pneumoconiosis; Silica, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- 183 participants
- Enrollment target
- 1
- Study location
Study Summary
Silicosis, a preventable yet irreversible occupational lung disease, has an insidious onset with a latency period for diagnosis extending beyond 10 years from the initial exposure. The central hypothesis of this study is that silicosis cases may currently be going undetected. The long-term goal of this research is to determine the current prevalence and forecast the future prevalence of silicosis and other pneumoconiosis among working populations in Oklahoma and to assist the public health and the healthcare system in planning for a potential resurgence of silicosis.
Primary Outcome
Estimate of average cumulative respirable crystalline silica exposure (semi-quantitative)
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Pulmonary Function Test
- DIAGNOSTIC_TEST Tuberculosis test
- DIAGNOSTIC_TEST Chest X-ray
Study Locations (1)
Oklahoma
- University of Oklahoma Health Sciences Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2019-01-14 |
| Est. Completion | 2022-06-10 |
What the finished NCT04205708 record still lists
NCT04205708 is an observational study that tracks outcomes without assigning an intervention. The registered 183 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Silicosis appearing as the primary indexed condition, and to 3 interventions - of which Pulmonary Function Test is the first listed.
NCT04205708 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT04205708 about?
NCT04205708 is a clinical study titled "Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma". Silicosis, a preventable yet irreversible occupational lung disease, has an insidious onset with a latency period for diagnosis extending beyond 10 years from the initial exposure. The central hypothesis of this study is that silicosis cases may currently be going undetected. The long-term goal of t...
What is the current status of trial NCT04205708?
This trial is currently completed. The enrollment target is 183 participants. The study started on 2019-01-14. Estimated completion is 2022-06-10.
What conditions does trial NCT04205708 study?
This clinical trial studies the following conditions: Silicosis, Pneumoconiosis; Silica.
What interventions are being tested in trial NCT04205708?
The interventions under investigation include: Pulmonary Function Test (DIAGNOSTIC_TEST), Tuberculosis test (DIAGNOSTIC_TEST), Chest X-ray (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04205708?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04205708 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03859297 · 183 participants · NA
Mechanisms of Rumination Change in Adolescent Depression
- NCT04270591 · 183 participants · Phase 1
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
- NCT06764615 · 183 participants · Phase 2
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- NCT06872684 · 183 participants · NA
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI